Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer

Q Zhang, B Chang, Q Feng, L Li - European Journal of Medicinal Chemistry, 2023 - Elsevier
Triple-negative breast cancer (TNBC) has become a serious threat to women's health.
Research on epigenetic drugs is gradually deepening and is expected to provide new …
被引用次数：2 相关文章

Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer

Q Zhang, B Chang, Q Feng, L Li - European journal of medicinal … - pubmed.ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) has become a serious threat to women's health.
Research on epigenetic drugs is gradually deepening and is expected to provide new …

Discovery of novel G9a/GLP covalent inhibitors for the treatment of triple-negative breast cancer.

Q Zhang, B Chang, Q Feng, L Li - European Journal of Medicinal …, 2023 - europepmc.org
Triple-negative breast cancer (TNBC) has become a serious threat to women's health.
Research on epigenetic drugs is gradually deepening and is expected to provide new …